Skip to content
World of Video Gaming – Lifestyle
Home
Sample Page
Author:
AbbVie Inc.
AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults
March 9, 2026